181 related articles for article (PubMed ID: 15195124)
1. PC-SPES: a herbal therapy for the treatment of hormone refractory prostate cancer.
Meyer JP; Gillatt DA
Prostate Cancer Prostatic Dis; 2002; 5(1):13-5. PubMed ID: 15195124
[TBL] [Abstract][Full Text] [Related]
2. Gene profiling and promoter reporter assays: novel tools for comparing the biological effects of botanical extracts on human prostate cancer cells and understanding their mechanisms of action.
Bigler D; Gulding KM; Dann R; Sheabar FZ; Conaway MR; Theodorescu D
Oncogene; 2003 Feb; 22(8):1261-72. PubMed ID: 12606954
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of action of herbal supplement PC-SPES: elucidation of effects of individual herbs of PC-SPES on proliferation and prostate specific gene expression in androgen-dependent LNCaP cells.
Hsieh TC; Wu JM
Int J Oncol; 2002 Mar; 20(3):583-8. PubMed ID: 11836572
[TBL] [Abstract][Full Text] [Related]
4. Phase I trial of PC-Spes2 in advanced hormone refractory prostate cancer.
Shabbir M; Love J; Montgomery B
Oncol Rep; 2008 Mar; 19(3):831-5. PubMed ID: 18288423
[TBL] [Abstract][Full Text] [Related]
5. Prospective, multicenter, randomized phase II trial of the herbal supplement, PC-SPES, and diethylstilbestrol in patients with androgen-independent prostate cancer.
Oh WK; Kantoff PW; Weinberg V; Jones G; Rini BI; Derynck MK; Bok R; Smith MR; Bubley GJ; Rosen RT; DiPaola RS; Small EJ
J Clin Oncol; 2004 Sep; 22(18):3705-12. PubMed ID: 15289492
[TBL] [Abstract][Full Text] [Related]
6. UsToo PC-SPES surveys: review of studies and update of previous survey results.
Porterfield H
Mol Urol; 2000; 4(3):289-91;discussion 293. PubMed ID: 11062386
[TBL] [Abstract][Full Text] [Related]
7. Role of herbal compounds (PC-SPES) in hormone-refractory prostate cancer: two case reports.
de la Taille A; Hayek OR; Burchardt M; Burchardt T; Katz AE
J Altern Complement Med; 2000 Oct; 6(5):449-51. PubMed ID: 11059508
[TBL] [Abstract][Full Text] [Related]
8. [PC-SPES and ProstaSol: Chinese herbal medicine as a treatment for prostate cancer].
Jensen JB; Langkilde NC
Ugeskr Laeger; 2004 Dec; 166(50):4611-2. PubMed ID: 15633553
[No Abstract] [Full Text] [Related]
9. Complementary and alternative therapies in prostate cancer.
Oh WK; Small EJ
Semin Oncol; 2002 Dec; 29(6):575-84. PubMed ID: 12516040
[TBL] [Abstract][Full Text] [Related]
10. Disseminated intravascular coagulation and PC-SPES: a case report and literature review.
Lock M; Loblaw DA; Choo R; Imrie K
Can J Urol; 2001 Aug; 8(4):1326-9. PubMed ID: 11564276
[TBL] [Abstract][Full Text] [Related]
11. Prospective trial of the herbal supplement PC-SPES in patients with progressive prostate cancer.
Small EJ; Frohlich MW; Bok R; Shinohara K; Grossfeld G; Rozenblat Z; Kelly WK; Corry M; Reese DM
J Clin Oncol; 2000 Nov; 18(21):3595-603. PubMed ID: 11054432
[TBL] [Abstract][Full Text] [Related]
12. PC-SPES withdrawal response.
Chaudhary UB; Rashid M; Keane TE
Acta Oncol; 2004; 43(8):772-3. PubMed ID: 15764226
[No Abstract] [Full Text] [Related]
13. [PC SPES in prostatic cancer: critical review of the literature].
de la Taille A
Prog Urol; 2001 Jun; 11(3):428-32. PubMed ID: 11512453
[TBL] [Abstract][Full Text] [Related]
14. The mechanism of action of estrogen in castration-resistant prostate cancer: clues from hormone levels.
Aggarwal R; Weinberg V; Small EJ; Oh W; Rushakoff R; Ryan CJ
Clin Genitourin Cancer; 2009 Oct; 7(3):E71-6. PubMed ID: 19815485
[TBL] [Abstract][Full Text] [Related]
15. Prospective randomized Phase II trial of pegylated doxorubicin in the management of symptomatic hormone-refractory prostate carcinoma.
Heidenreich A; Sommer F; Ohlmann CH; Schrader AJ; Olbert P; Goecke J; Engelmann UH
Cancer; 2004 Sep; 101(5):948-56. PubMed ID: 15329902
[TBL] [Abstract][Full Text] [Related]
16. PC-SPES, a dietary supplement for the treatment of hormone-refractory prostate cancer.
Pfeifer BL; Pirani JF; Hamann SR; Klippel KF
BJU Int; 2000 Mar; 85(4):481-5. PubMed ID: 10691828
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer and the food supplement, PC-SPES. Minireview.
Thomson JO; Dzubak P; Hajduch M
Neoplasma; 2002; 49(2):69-74. PubMed ID: 12088108
[TBL] [Abstract][Full Text] [Related]
18. Ponicidin and oridonin are responsible for the antiangiogenic activity of Rabdosia rubescens, a constituent of the herbal supplement PC SPES.
Meade-Tollin LC; Wijeratne EM; Cooper D; Guild M; Jon E; Fritz A; Zhou GX; Whitesell L; Liang JY; Gunatilaka AA
J Nat Prod; 2004 Jan; 67(1):2-4. PubMed ID: 14738375
[TBL] [Abstract][Full Text] [Related]
19. PC-SPES and prostate cancer.
Oh WK; Small EJ
Urol Clin North Am; 2002 Feb; 29(1):59-66, viii. PubMed ID: 12109356
[TBL] [Abstract][Full Text] [Related]
20. PC-SPES: hope or hype?
Kosty MP
J Clin Oncol; 2004 Sep; 22(18):3657-9. PubMed ID: 15289490
[No Abstract] [Full Text] [Related]
[Next] [New Search]
